MAZEFundraisingglobenewswire

Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement

Sentiment:Positive (70)

Summary

(NASDAQ:MAZE) Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on September 11, 2025 by globenewswire